
Sign up to save your podcasts
Or
Interesting trial this week evaluating a fixed schedule of rituximab vs. a tailored approach to therapy. See you all at ACR this week!
4.9
111111 ratings
Interesting trial this week evaluating a fixed schedule of rituximab vs. a tailored approach to therapy. See you all at ACR this week!
318 Listeners
498 Listeners
125 Listeners
3,332 Listeners
1,105 Listeners
119 Listeners
195 Listeners
517 Listeners
350 Listeners
168 Listeners
71 Listeners
4 Listeners
174 Listeners
6 Listeners
19 Listeners